Skip to main content
رجوع
Watch Compare

Zura Bio Ltd

جودة البيانات: 83%
ZURA
Nasdaq Manufacturing Chemicals
KWD 5.62
▼ KWD 0.08 (-1.39%)
القيمة السوقية: 533.32 M
السعر
KWD 5.62
القيمة السوقية
533.32 M
نطاق اليوم
KWD 5.55 — KWD 5.81
نطاق 52 أسبوعًا
KWD 0.98 — KWD 7.44
حجم التداول
407,352
فتح KWD 5.67
متوسط 50 يوم / 200 يوم
KWD 6.26
10.15% below
متوسط 50 يوم / 200 يوم
KWD 3.82
47.19% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -64.93 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-58.64%
أقل من متوسط القطاع (-53.41%)
ROIC-46.16%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio5.58
Interest CoverageN/A

التقييم

PE (TTM)
-7.77
أقل من متوسط القطاع (-1.48)
P/B Ratio4.93
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -7.8 -1.5
P/B 4.9 1.6
ROE % -58.6 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -68.65 M
ROE -58.64% ROA -45.50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -64.93 M
ROIC -46.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.58
Interest Coverage N/A Asset Turnover N/A
Working Capital 116.80 M Tangible Book Value 108.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.77 Forward P/E N/A
P/B Ratio 4.93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12.17%
Market Cap 533.32 M Enterprise Value 394.31 M
Per Share
EPS (Diluted TTM) -1.06 Revenue / Share N/A
FCF / Share -0.68 OCF / Share -0.68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 94.58%
SBC-Adj. FCF -83.33 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -68.65 M -52.40 M -60.36 M 6.85 M 3.55 M
EPS (Diluted) -1.06 -0.60 -2.09 — —
Gross Profit — — — — —
Operating Income -75.25 M -55.19 M -62.64 M -888,545.0 -2.68 M
EBITDA — — — — —
R&D Expenses 42.08 M 24.40 M 44.00 M — —
SG&A Expenses — — — — —
D&A 49,000.0 9,000.0 — — —
Interest Expense — — — — —
Income Tax — 0.0 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 113.95 M 179.53 M 100.84 M 140.55 M 141.51 M
Total Liabilities 12.41 M 19.51 M 21.29 M 10.35 M 7.76 M
Shareholders' Equity 101.54 M 146.82 M 59.33 M -9.18 M -7.63 M
Total Debt — — — — —
Cash & Equivalents 109.41 M 176.50 M 99.80 M 729,223.0 13,785.0
Current Assets 112.31 M 178.74 M 100.84 M 1.15 M 33,487.0
Current Liabilities 12.41 M 19.51 M 20.30 M 272,292.0 1.83 M